Editorial commentary: ACL tissue bioengineering clinical application is in its infancy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25953227.
- Also identified by DOI 10.1016/j.arthro.2015.02.036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Preclinical ACL tissue engineering studies show promise using a combination of cells, scaffolds, growth factors, and "stimulation," such as ultrasound or shockwave therapy, but clinical application is in its infancy. Bioactive scaffolds may be weak at time zero. A solution could be to add to the combination of cells, scaffolds, growth factors, simulation, and a structural tie.
Medical subject headings
- Knee Joint
- Ligaments, Articular
- Tissue Engineering
Anatomy
- knee